Sitravatinib, Tislelizumab, Sitravatinib
GEM-2101
Phase 2 small_molecule active
Quick answer
Sitravatinib, Tislelizumab, Sitravatinib for Uveal melanoma is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Uveal melanoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active